Webcast
Event Title
Identification of Medicinal Products: Path to Global Implementation
June 11, 2021
- Date:
- June 11, 2021
- Time:
-
1:00 PM - 2:30 PM ET
Attend
Visit CDER Small Business and Industry Assistance Webpage
FDA will present updates on the Identification of Medicinal Products (IDMP) standards development and implementation with an emphasis on international collaboration, pilot projects on substance, dosage form and pharmaceutical identification (PhPID).
TOPICS
- Overview of FDA’s Approach to IDMP and its global implementation
- Collaboration with European Union (EU) European Medicines Agency on the implementation of the Global Substance Registration System (GSRS) and EU Substance Registration System (SRS)
- Outcome of an international pilot evaluation to demonstrate the use of dose form characteristics as input in the generation of PhPID
- GSRS a useful tool for substance registration in small businesses
INTENDED AUDIENCE
Pharmaceutical and regulatory authority professionals working in areas such as pharmacovigilance, product labeling, electronic submissions, and data standards.
FDA SPEAKERS
Ron Fitzmartin, PhD, MBA
Sr. Informatics Advisor
Office of the Director | Center for Biologics Evaluation and Research (CBER)
Ta-Jen Chen
Project Management Officer
Office of Strategic Programs | Center for Drug Evaluation and Research (CDER)
Tyler Peryea
Chemist
Office of Health Informatics (OHI) | Office of Chief Scientist (OCS)
Lawrence Callahan, PhD
Chemist
OHI | OCS
FDA RESOURCES
CONTINUING EDUCATION
Real-time attendance is required for the certificate of attendance which can be used in support of CEs for the following professional organizations. Certificates are only available during the two weeks post-event.
This course:
- has been pre-approved by RAPS as eligible for credits (appropriate to real-time attendance) towards a participant’s RAC recertification upon full completion.
- has been pre-approved by SOCRA who accepts documentation of candidate participation in continuing education programs for re-certification if the program is applicable to clinical research regulations, operations or management, or to the candidate's clinical research therapeutic area.
- has been pre-approved by SQA as eligible for 1 non-GCP or non-GLP unit for every 1 hour of instructional time towards a participant’s RQAP re-registration.
- has been approved by ACRP for continuing education in clinical research. ACRP will provide 1 ACRP contact hour for every 45-60 minutes of qualified material.
TECHNICAL INFORMATION AND QUESTIONS
- To optimize webinar experience, use Chrome when viewing AdobeConnect in a browser.
- Please contact info@sbiaevents.com for all technical questions.
- If you encounter any technical issues before or during the event, please visit the Technical Issues Support Page for help.
- Test your PC for use with Adobe Connect prior to the day of the event.
https://concerted.adobeconnect.com/common/help/en/support/meeting_test.htm
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.